Compounds > 3-methyl-4',6-dihydroxy-3',5'-dibromoflavone
Page last updated: 2024-09-03

3-methyl-4',6-dihydroxy-3',5'-dibromoflavone and sulfobromophthalein

3-methyl-4',6-dihydroxy-3',5'-dibromoflavone has been researched along with sulfobromophthalein in 1 studies

Compound Research Comparison

Studies
(3-methyl-4',6-dihydroxy-3',5'-dibromoflavone)		Trials
(3-methyl-4',6-dihydroxy-3',5'-dibromoflavone)		Recent Studies (post-2010)
(3-methyl-4',6-dihydroxy-3',5'-dibromoflavone)		Studies
(sulfobromophthalein)		Trials
(sulfobromophthalein)		Recent Studies (post-2010) (sulfobromophthalein)
13003,2093346

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, JW; Curtis, AJ; Loidl, NM; Raggatt, LE; Stockigt, JR; Topliss, DJ1

Other Studies

1 other study(ies) available for 3-methyl-4',6-dihydroxy-3',5'-dibromoflavone and sulfobromophthalein

ArticleYear
Drug competition for intracellular triiodothyronine-binding sites.
    European journal of endocrinology, 1994, Volume: 130, Issue:4

    Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; Carcinoma, Hepatocellular; Fatty Acids, Nonesterified; Flavonoids; Furosemide; Humans; Iodide Peroxidase; Liver; Liver Neoplasms; Macaca fascicularis; Sex Hormone-Binding Globulin; Sulfobromophthalein; Triiodothyronine; Tumor Cells, Cultured

1994